AUDIT QUALITY AND EARNINGS MANAGEMENT OF PHARMACEUTICAL COMPANIES LISTED IN NIGERIA

Authors

  • Theresa N. Obi Department of Accountancy, Nnamdi Azikiwe University, Awka, Nigeria
  • Pius V.C. Okoye Department of Accountancy, Nnamdi Azikiwe University, Awka, Nigeria

Keywords:

Audit fee, Audit firm size, Audit firm specialization, Audit quality, Audit tenure,, Discretionary accruals, Earnings management

Abstract

 This study  focused  on audit quality on earnings management of listed  Nigerian pharmaceutical companies with the following objectives:  To examine the effect of audit firm size on discretionary accrual of listed Pharmaceutical companies in Nigeria; to assess the effect of audit tenure on discretionary accrual of listed Pharmaceutical companies in Nigeria; to ascertain the effect of audit fee on discretionary accrual of listed Pharmaceutical companies in Nigeria; to evaluate the effect of audit firm specialization on discretionary accrual of listed Pharmaceutical companies in Nigeria.. A total of seven pharmaceutical companies listed on the floor of the Nigerian Exchange (NGX) Group as at 31st December 2021 were sampled.  The data were sourced from publications of the Nigerian stock exchange (NSE), fact books and the annual report and accounts of the sampled pharmaceutical companies. Pearson correlation coefficient and panel least square (PLS) regression were used for analysis of the pharmaceutical companies for the years 2010 – 2021. Based on the analyzed results, the following summary of findings was provided: audit firm tenure has a significant but positive effect on discretionary accrual of listed pharmaceutical companies in Nigeria at 5% level of significance while audit firm size, audit fee and audit firm specialization has a significant but negative effect on discretionary accrual of listed pharmaceutical companies in Nigeria at 5% level of significance. This study concluded that; Audit Firm Size has a significant but negative effect on Discretionary Accrual; Audit Tenure has a significant and positive effect on Discretionary Accrual; Audit Fee has a significant but negative effect on Discretionary Accrual; Audit Firm Specialization has a significant but negative effect on Discretionary Accrual of listed Pharmaceutical companies in Nigeria at 5% level of significance. The following recommendations were made: that firms should always consider competence and experience of the audit firms rather than size that are likely to be associated with less earnings management of firms; accounting professional bodies should strictly ensure that their members who audit for their clients do not audit for more than three years at a spring to sphere the independence of the auditor and his/her objectivity; firms should find ways to lower audit cost by negotiating the audit services to be assessed in rates and hours, not just total fee level; that Auditors should have knowledge not only in auditing and accounting but also on clients’ industry to deliver higher quality audit services than one audited by non-specialized auditor.

Downloads

Published

2023-09-30

How to Cite

Obi, T. N., & Okoye, P. V. (2023). AUDIT QUALITY AND EARNINGS MANAGEMENT OF PHARMACEUTICAL COMPANIES LISTED IN NIGERIA. Journal of Global Accounting, 9(3), 322–341. Retrieved from https://journals.unizik.edu.ng/joga/article/view/2671

Issue

Vol. 9 No. 3 (2023): September

Section

Articles

License

Copyright (c) 2023 Journal of Global Accounting

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Articles submitted to JOGA should not have been published or are currently under review by another Journal. Kindly see the guide for the preparation of the manuscript for details. Successful submission of articles by author(s) for publication clearly implies that the work is not an infringement of any existing copyright warranty as JOGA reserves the right to be indemnified by the author(s) where any breach of such warranty is proven. For ease of dissemination and to ensure proper policing of use, papers and contributions become the legal copyright of JOGA once published unless otherwise agreed.

Permission clearance should be obtained by the author(s) where applicable for the use of any content of interest not originally created by them. This must be done before the submission of the article to JOGA. Failure to do so may lead to a lengthy delay in publication, as JOGA is unable to publish any article which has permissions pending. Thus, the rights JOGA requires are:

  1. Non-exclusive right to reproduce the material in the article or book chapters.
  2. Print and electronic rights.
  3. To use the material for the life of the work (for instance, there should be no time restrictions on the re-use of material).

Where tables, figures or excerpts of more than 250 words are reproduced from another source, it is expected that:

  1. Author(s) should obtain the necessary written permission in advance from any third-party owner of the copyright for the use in print and electronic formats of any of their text, illustrations, graphics, or other material in their manuscript. Permission must also be cleared for any minor adaptations of any work not originally created by the author(s). The author (s) should not assume that any content freely available on the web is free to use.
  2. Where the author adapts a significant number of any material, the author(s) must inform the copyright holder of the original work.
  3. Author obtains any proof of consent statements
  4. The author must acknowledge figure(s) and content adopted or adapted in work utilizing source(s) and further capture them in the list of references.